We use cookies to improve your experience. By your continued use of this site you accept such use.
African Development Bank Group (AfDB)

  • Multimedia content

  • Images (1)
    • Visiting the IPD in January 2024, the President of the African Development Bank Group, Akinwumi Adesina ((1st right), announced its support for this important biomedical research centre in Africa
  • All (1)
Source: African Development Bank Group (AfDB) |

Global Partners Invest $45 Million to Boost African Vaccine Production

This collaboration will focus on expanding IPD’s state-of-the-art MADIBA facility, a hub for vaccine manufacturing, while driving job creation and economic growth

In significant efforts to strengthen public health and improve vaccine access in Africa, the U.S. International Development Finance Corporation, the African Development Bank (www.AfDB.org), and the International Finance Corporation (IFC) have jointly announced a $45 million financing package for VaxSen, a subsidiary of Senegal’s Institut Pasteur de Dakar (IPD). The…

EVA Pharma

  • Multimedia content

  • Images (1)
    • Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
  • All (1)
Source: EVA Pharma |

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

This milestone stems from the companies’ collaboration to expand access to affordable insulin to one million people living with diabetes in low-to middle-income countries annually by 2030

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma (www.EVAPharma.com) through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the collaboration aims to deliver a sustainable supply of high-quality, affordable human and analog insulin to at least one million people annually living with…

BRICS Competition Law and Policy Centre
Source: BRICS Competition Law and Policy Centre |

BRICS countries will create a barrier-free regulatory regime for biosimilars

Experts of the BRICS Working Group on Competition in Pharmaceutical Markets call for the removal of barriers to the regulation of the turnover of biological drugs and biosimilars in the BRICS+ countries

The HSE University BRICS Competition Law and Policy Centre (www.BRICSCompetition.org) has summarised the first results of its annual analytical study on bringing biotechnological drugs to the BRICS market. One of the conclusions of the report was the need to conduct a large-scale sectoral study on the removal of barriers in…

World Health Organization (WHO) - Ethiopia
Source: World Health Organization (WHO) - Ethiopia |

World Health Organization (WHO) Receives Certificate of Merit for Contributions to Ethiopia's Pharmaceutical Sector

Established in 1974, the Ethiopian Pharmaceutical Association is a national body representing pharmacists in Ethiopia

The World Health Organization (WHO) has been awarded a Certificate of Merit by the Ethiopian Pharmaceutical Association (EPA) in recognition of its outstanding contributions to the pharmaceutical sector. The award was presented during EPA's celebration of its 50-year journey. WHO was honored for its extensive efforts in strengthening Ethiopia’s regulatory…

Informa Markets: Healthcare

  • Multimedia content

  • Images (3)
    • International Health Ministerial Summit (1)
    • International Health Ministerial Summit (2)
    • International Health Ministerial Summit (3)
  • All (3)
Source: Informa Markets: Healthcare |

Health equity and women’s health emerge as key themes of the inaugural International Health Ministerial Summit

The exclusive by-invitation only Summit, themed Strengthening Health Systems for a Better Tomorrow, takes place from 4 to 5 December 2024 at the Marriott in Kigali

The inaugural International Health Ministerial Summit, organised by Informa Markets (www.InformaMarkets.com), began with a series of dynamic panel discussions featuring influential delegates showcasing collaborative solutions to global healthcare challenges. Hosting governmental figures and policymakers, corporate CEOs and investors, medical directors, and experts, the exclusive by-invitation only Summit, themed Strengthening Health…

Afreximbank

  • Multimedia content

  • Images (1)
    • Mr. Zitto Alfayo, Head of Project Preparation at Afreximbank (left), and Dr. Dhiren Thakker, CEO of Med Aditus (right), sign the agreement in Kisumu, Kenya. Looking on are Mrs. Kanayo Awani, Executive Vice President, Intra-African Trade and Export Development at Afreximbank, and Prof. Peter Anyang’ Nyong’o, Governor of Kisumu County
  • All (1)
Source: Afreximbank |

Afreximbank partners with Med Aditus to boost local pharmaceutical production of essential medicines in Kenya

Afreximbank’s intervention is part of its ‘Africa Health Security Investment Plan” to support the health product manufacturing ambition of the continent

African Export-Import Bank (Afreximbank) (www.Afreximbank.com) and Kenya-based Med Aditus Pharmaceutical Kenya Limited (Med Aditus) have signed a project preparation facility heads of terms agreement at the margins of the fourth edition of the African Sub-Sovereign Governments Network (AfSNET) Conference in Kisumu City, Kenya. The project preparation facility will be deployed…

Médecins sans frontières (MSF)
Source: Médecins sans frontières (MSF) |

Médecins sans frontières (MSF) to roll out injectable Human Immunodeficiency Virus (HIV) prevention drug in southern Africa

Increasing access to this long-acting preventive medicine could be a game changer in curbing the spread of HIV/AIDS

As World AIDS Day approaches on December 1, Doctors Without Borders/Médecins Sans Frontières (MSF) is preparing to roll out long-acting cabotegravir (CAB-LA) for pre-exposure prophylaxis (PrEP) in its projects in southern Africa. CAB-LA, administered as an injection every two months, has been described as a potential game changer in the fight…

World Health Organization (WHO) - Nigeria
Source: World Health Organization (WHO) - Nigeria |

Addressing the challenges of antimicrobial resistance in Africa

Empowering communities to take ownership of AMR interventions is very key

Antimicrobial resistance (AMR) is one of the top global public health and development threats. About 4.71 million deaths were linked to bacterial AMR in 2021 alone, with sub-Saharan Africa accounting for highest mortality rates. AMR could be responsible for up to 2 million deaths in Africa by 2050, underscoring the need…

CPHI Middle East

  • Multimedia content

  • Images (3)
    • Stage set for international collaboration upscaling and regional market entries while health and environmental interplay come under the microscope
    • CPHI Middle East Attracts Global Hub Players as Region Advances BioTech and Pharma Capabilities
    • Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma convention in the region
  • All (3)
Source: CPHI Middle East |

CPHI Middle East Attracts Global Hub Players as Region Advances BioTech and Pharma Capabilities

Industry experts, influencers, and pioneers from the world’s top pharmaceutical hubs will gather at the inaugural CPHI Middle East – the most comprehensive pharma convention in the region

Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma convention in the region Stage set for international collaboration, upscaling, and regional market entries, while health and environmental interplay come under the microscope Industry trailblazers from over 100 nations across Africa,…

U.S. Embassy and Consulate in Nigeria
Source: U.S. Embassy and Consulate in Nigeria |

United States Agency for International Development (USAID) Announces $2.3 Million Commitment to Procure Life-Saving Malaria Tablets from Swiss Pharma

According to the World Health Organization (WHO), fewer than 10% of medicines manufactured in sub-Saharan Africa meet global standards, limiting local companies’ ability to supply essential drugs and meet healthcare needs

The U.S. Agency for International Development (USAID) has committed $2.3 million to procure 4.8 million doses of life-saving malaria tablets from Swiss Pharma (Swipha) in a landmark partnership that will expand access to essential medicines in Nigeria and West Africa. This procurement, to be facilitated through the U.S. Government’s President’s…